Fevrin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fevrin

Property Description
Active Ingredient Acetaminophen (Paracetamol)
Form Tablet, capsule, solution, suspension, suppository
Pharmacological Class Analgesic and Antipyretic
General Purpose Relief of pain and fever
Origin Synthetic compound

Fevrin: Definition, Composition, and General Purpose

Fevrin is a widely recognized, accessible non-opioid medication primarily defined by its capacity to alleviate general pain and reduce fever. Its active pharmaceutical ingredient is Acetaminophen, which is internationally known as Paracetamol, a compound classified chemically as a Para-aminophenol derivative.

Fevrin belongs to the pharmacological classes of Analgesics (pain relievers) and Antipyretics (fever reducers), providing symptomatic relief by modulating the body’s central pain and temperature responses. As an analgesic and antipyretic, the drug's general purpose is centered on offering symptomatic comfort, and its efficacy in this regard is clinically recognized. It is distinct from Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) because it generally lacks clinically significant anti-inflammatory effects in the body's periphery.


What Type of Drug is Acetaminophen?

Acetaminophen, the compound in Fevrin, is a synthetic pharmaceutical entity, meaning it is produced via chemical manufacturing rather than being derived directly from natural sources. It is most often formulated as a single-active ingredient product. A notable feature of formulations represented by Fevrin is its wide availability in specialized forms, such as flavored oral suspensions and various strengths, specifically to target pediatric patient groups.

Fevrin is available in diverse pharmaceutical forms to facilitate various routes of administration, including common oral preparations like the tablet, capsule, oral solution, and suspension. Specialized formulations, such as suppositories for rectal use and intravenous (IV) solutions for clinical settings, ensure the medicine can be administered when the oral route is not feasible. The required pharmaceutical excipients (the base/vehicle) are specific to each presentation, guaranteeing the stability and appropriate delivery of the active ingredient.

Regulatory References

  1. NIH MedlinePlus Acetaminophen
  2. Acetaminophen Drug Information
  3. NIH StatPearls

What side effects are possible with Fevrin?

Possible Side Effects and Safety Information

Fevrin, which contains Acetaminophen (Paracetamol), has an official safety profile primarily defined by the risk of hepatotoxicity (liver damage) and serious hypersensitivity reactions, as documented in regulatory sources like the FDA and EMA SmPC. The most critical safety consideration is the risk of acute liver failure, which is associated with exceeding the maximum recommended daily limit or concurrent use of other products containing the same active ingredient.

Adverse effects are formally categorized by system-organ class in regulatory documents, including effects on the Hepatic System, Skin and Subcutaneous Tissue, Immune System, and Blood and Lymphatic System. Certain reactions are classified by frequency, with severe skin reactions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) documented as very rare but serious adverse reactions. Hypersensitivity reactions, including anaphylaxis, are also noted.

Classification Examples of Reactions
Systemic Risk Acute liver failure, Anaphylaxis, Severe Skin Reactions
Rare Effects Thrombocytopenia, Hypotension, Elevated hepatic transaminases
Common Effects Nausea, Vomiting (noted in specific formulations)

Official labeling defines specific safety constraints, particularly for certain patient groups. Individuals with severe hepatic impairment or a history of chronic alcoholism are explicitly identified as being at higher risk. Furthermore, the risk of serious skin reactions is noted to potentially occur with the first-time use of the medication or at any point during treatment. Use is explicitly restricted from concurrent administration with other acetaminophen-containing products.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Fevrin (Acetaminophen/Paracetamol) is a serious, life-threatening event that is defined by the risk of severe liver damage and, potentially, acute hepatic failure [1.1, 3.5].

Documented Overdose Manifestations

Domain Official Regulatory Statements
Documented presentations Overdose may initially be asymptomatic or present with non-specific, transient symptoms including nausea, vomiting, sweating, anorexia, and malaise [1.2, 1.7]. Later signs include jaundice and upper right quadrant abdominal pain [1.7].
Physiological systems affected The primary risk is hepatic system damage leading to liver failure [1.1, 3.5]. Secondary effects include renal failure and neurological complications like hepatic encephalopathy in severe cases [1.7, 3.5].
Risk factors Risk of severe hepatotoxicity is officially documented as higher in patients with pre-existing liver disease or those who chronically ingest three or more alcoholic drinks per day [1.1, 3.7].

Emergency Action Required

Regulators mandate that individuals seek immediate medical attention for any known or suspected overdose [1.2]. This action is required even if the individual appears asymptomatic because severe injury can be developing in the absence of early signs [1.4]. Immediate assessment includes obtaining the serum acetaminophen concentration to guide risk determination [1.6]. The specific antidote, N-acetylcysteine (NAC), is documented for use to prevent or lessen hepatic injury, with maximum efficacy achieved when treatment is started early [2.4, 4.3].


Therapeutic Uses of Fevrin

Fevrin is commonly used to help with symptoms related to physical discomfort and systemic imbalance. This medication is utilized across therapeutic domains involving heightened symptoms, focusing on pain relief and fever reduction.

The medication is applied in addressing symptoms associated with acute or episodic changes, such as tension headaches, toothache, muscle aches, backache, and discomfort associated with osteoarthritis or menstrual cramps. Applied in contexts involving heightened systemic burden, it offers symptomatic relief that helps patients cope more steadily with symptom fluctuations.

“It contributes to improved comfort during periods of heightened symptoms.”

It is considered relevant when short-term symptomatic assistance is needed, assisting in managing symptoms related to heightened physiological activity, such as fever (elevated body temperature) and the accompanying malaise common in conditions like the cold or flu. Fevrin contributes to easing the overall symptom load and may assist with maintaining functional stability when symptoms interfere with routine activities.


Quick Fact: Relief for Mild to Moderate Pain and Fever


Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Fevrin?

Eligibility for Fevrin (Acetaminophen/Paracetamol) is defined by official regulatory labeling, specifying which populations are approved and which are restricted or contraindicated.

Eligibility Classifications

Fevrin is broadly approved for adults and adolescents. Its use in pediatric populations (infants and children) is established, though the minimum eligible age depends on the specific product's formulation and concentration (e.g., some suspensions are approved for infants as young as 2 months).

Classification Population/Condition Restriction Detail
Contraindicated Documented Hypersensitivity to Acetaminophen Prohibited due to risk of severe allergic reaction.
Contraindicated Severe Active Hepatic Impairment Prohibited due to significant risk of hepatotoxicity.
Conditional Use Severe Renal Impairment Requires caution and adherence to mandated dose interval changes.
Conditional Use Chronic Alcoholism/Malnutrition Requires caution; official labels advise on potential reduced maximum daily dose.

Pregnancy and Breastfeeding Status

Fevrin is generally considered compatible with breastfeeding. During pregnancy, it is classified as acceptable for use when clinically necessary, but official guidelines advise using the lowest effective dose for the shortest possible duration.

What should I know about interactions with other medicines?

Fevrin Interactions with other medicines and products

The official regulatory profile for Fevrin (Acetaminophen/Paracetamol) focuses on substances that alter its clearance or potentiate risks. A formal prohibition exists against co-administering Fevrin with any other product containing acetaminophen due to the severe risk of dose-dependent liver damage. The consumption of three or more alcoholic drinks every day while using Fevrin significantly increases the risk of severe hepatotoxicity, a risk similarly heightened by enzyme-inducing agents like Phenytoin, Phenobarbital, and Carbamazepine.

A key pharmacokinetic interaction occurs with Probenecid, which inhibits the conjugation pathway, resulting in an almost two-fold reduction in Fevrin's clearance. This raises drug exposure in the body. Other medicines, including Isoniazid and Zidovudine, have also been documented to affect Fevrin metabolism, with Zidovudine co-use associated with increased risks of neutropenia. Conversely, the absorption rate of Fevrin is increased by co-administration with Metoclopramide or Domperidone.

The pharmacodynamic interaction with Warfarin and related oral anticoagulants is clinically relevant; prolonged, regular daily use of Fevrin may enhance the anticoagulant effect, increasing the documented risk of bleeding. A timing constraint requires separating Fevrin administration from Colestyramine by at least one hour to prevent a reduction in the rate of Fevrin absorption. Use is contraindicated in patients with severe hepatic impairment due to a heightened susceptibility to accumulation risks.

Mechanism of Action

Fevrin exerts its physiological effects through a dual mechanism that modulates neurotransmitter availability and intracellular signaling. The combined activity of these mechanisms leads to a gradual, sustained adjustment of chemical signaling pathways in the central nervous system.

Regulating Serotonin Availability

Fevrin acts as a selective inhibitor of the Serotonin Transporter (SERT), a protein responsible for reuptake of the neurotransmitter serotonin from the synaptic cleft . By blocking SERT, Fevrin increases the extracellular concentration of serotonin, which enhances and prolongs signaling in central serotonergic pathways, affecting signal transmission.

Influencing Cellular Signaling

Fevrin also engages with the Sigma-1 Receptor (sigma1 receptor), an intracellular protein linked to cellular integrity and neuronal adaptation. This action modulates internal cellular processes and is associated with changes in neuronal adaptation pathways. The integration of both SERT inhibition and sigma1 receptor modulation drives a progressive adaptation of neural circuitry, which shapes the resulting system-level physiological modulation.

Dosage and Administration Information

Administration Guidelines for Fevrin (Acetaminophen/Paracetamol)

Fevrin is administered according to standardized dosing protocols involving the route, frequency, and maximum allowable dose. The medication is available for Oral use (tablet, solution, suspension), Rectal use (suppository), and for Intravenous (IV) Infusion in clinical settings.

Dosage and Frequency

The general principle for administration centers on adhering to a strict minimum time interval between doses and a critical 24-hour maximum. The standard single dose for adults weighing 50 kg or more ranges from 650 mg to 1,000 mg, with a required minimum of four hours between immediate-release doses. The recommended maximum total dose in a 24-hour period is 4,000 mg (4 g), though some over-the-counter labels specify a lower daily maximum.

Administration Pattern Labeled Dosing Schedule
Immediate-Release Forms Every 4 to 6 hours as needed.
Extended-Release Forms Every 8 hours, swallowed whole.
IV Infusion Administered over 15 minutes in a controlled setting.

Procedural and Population Rules

Administration requires the use of a dosing device supplied with the product when using oral suspensions to ensure accuracy. A critical instruction is to not use Fevrin with any other medicine containing acetaminophen to prevent accidentally exceeding the maximum daily dose. Furthermore, the dosing protocol mandates adjustments for certain populations; for instance, patients with renal or hepatic impairment or those weighing less than 50 kg may require a reduced daily maximum dose or an extended interval between doses. OTC use is generally limited to a maximum of 10 days for pain or 3 days for fever without professional consultation.

Recent Clinical Evidence

Research evidence / Overview of studies for Fevrin


Evidence for Use in Acute Pain Relief

Research has extensively explored the use of Fevrin in studies examining outcomes related to physical discomfort that is categorized as mild to moderate, often associated with short-term or acute episodes. The research approach has utilized short-term Randomized Controlled Trials (RCTs) and systematic reviews that pool data from multiple studies. Researchers examined the time required to measure initial relief and the duration of measured pain changes as key outcomes. Studies conducted during periods of increased symptom activity reported measurable changes in pain intensity in treated subjects across various acute settings.

Studies of Specific Pain Conditions

Research examined Fevrin's role in specific patient cohorts experiencing conditions characterized by fluctuating or episodic manifestations, such as tension headaches and toothache. Studies explored changes related to physical discomfort using patient-reported outcomes describing perceived discomfort. For many of these specific conditions, the research highlights that findings describe patterns observed only over a limited time frame, and results apply only to the populations studied.


Evidence for Use in Fever Reduction (Antipyretic Studies)

Fevrin was studied for its use in conditions involving periods of heightened symptoms, specifically fever (pyrexia). Controlled trials reported findings describing patterns showing measurable changes in body temperature in observed subjects compared to control groups over defined time intervals. Research describes the timing of the measured peak effect and the subsequent measured changes in temperature in the observed populations. These findings help contextualize how patients reported their experience of outcomes related to systemic or functional imbalance.


Evidence in Special Populations

Fevrin was evaluated in specific patient groups, particularly children (pediatric patients) and older adults. For pediatric patients, extensive research has explored Fevrin's role, primarily for fever reduction, with a high volume of controlled trials. Studies in these populations primarily monitored outcomes related to functional status or activity level in the short term. Research is ongoing, but data for certain groups, such as those with significant comorbidities or pregnant populations, remains insufficient.


What is Still Uncertain About Fevrin

The evidence highlights what is known and what is still uncertain regarding the research on Fevrin. A key limitation is that most definitive research focuses on short-term outcomes related to physical discomfort, meaning there is limited information for long-term outcomes or continuous daily use. Furthermore, the structural evidence indicates that comparative research against newer treatments requires ongoing investigation.

Key Studies & References

  1. Analgesic Efficacy of Paracetamol for Acute Pain: A Systematic Review and Meta-analysis
  2. NICE Guideline: Osteoarthritis: care and management (specifically for initial analgesics)

Frequently Asked Questions (FAQ)

Common questions about Fevrin (FAQ)


Q: What is the main reason Fevrin is prescribed?

According to official documents, Fevrin is approved to act as an analgesic and an antipyretic. This means the main reasons for its use are relieving mild to moderate pain and reducing fever.

Q: Is Fevrin the same type of medicine as [Common over-the-counter drug]?

Regulatory information classifies the active ingredient in Fevrin, Acetaminophen (Paracetamol), as a medication belonging to the analgesic (pain reliever) and antipyretic (fever reducer) drug classes. Many other over-the-counter products also fall into these broad categories, though their chemical structure and effects may differ.

Q: Does Fevrin have a generic version available?

Yes, the active component of Fevrin, which is Acetaminophen (or Paracetamol), is an established and common medication available in many generic and non-prescription forms. The availability of generic alternatives is often determined by regulatory approval processes.

Q: How quickly can I expect Fevrin to start working?

Based on pharmacokinetic research, the drug generally reaches its peak concentration in the bloodstream approximately 10 to 60 minutes after it is taken orally. This indicates the period when the medication is typically observed to be at its highest concentration in the body, based on research.

Q: What are the most commonly reported side effects of Fevrin?

The most frequently reported adverse events in clinical summaries include common gastrointestinal effects such as nausea and vomiting. Other general effects, such as a loss of appetite or tiredness, are also sometimes noted in the official safety profile.

Q: Is it normal to feel tired when first taking Fevrin?

While not a universal experience, regulatory documents list reports of fatigue and unusual tiredness or weakness among the general adverse events observed in subjects using the medication. This type of effect is acknowledged in the official safety information.

Q: Are there any foods or drinks that should be avoided while using Fevrin?

Official regulatory documents contain a strong caution regarding the use of Fevrin with alcohol. Specifically, chronic consumption of three or more alcoholic drinks per day is associated with an increased risk of severe hepatotoxicity (liver damage).

Q: Does Fevrin interact with common supplements like vitamins or herbal remedies?

Regulatory documents contain the recommendation that patients should inform their healthcare provider about all other products used, including vitamins, herbal remedies, and supplements. This is because potential interactions with Fevrin may exist that could alter the medication's effects or clearance.

Q: What happens if I miss taking a dose of Fevrin?

For the oral and rectal forms, this medication is typically taken as needed for short-term symptoms. Therefore, official guidelines emphasize the critical need to maintain the required minimum time interval between doses and the primary caution is to avoid exceeding the maximum dose allowed within a 24-hour period.

Q: Is Fevrin considered safe for older adults?

Official dosing standards indicate that individuals in this age group (aged 60 years and above) may require adjustments to the maximum daily dose. Regulatory guidance also cautions that, as with many medications, regular monitoring by a healthcare professional is essential when the drug is used by this population.

Q: Why can't people with a history of kidney problems use Fevrin?

The official guidelines explain that patients with severe renal (kidney) impairment or end-stage renal disease may require dosage modifications. This is because the drug's elimination from the body, which occurs partially through the kidneys, is affected in this population.

Q: Is Fevrin safe to use during pregnancy or while breastfeeding, according to regulatory information?

Regulatory and research summaries note that definitive data on the effects of Fevrin's use during pregnancy or breastfeeding is limited. Official guidance states that any use of this medication during pregnancy or breastfeeding requires careful assessment of potential risks and benefits.

Q: Can Fevrin be taken with caffeine?

Based on official drug interaction checkers, no major interaction has been identified between the active ingredient in Fevrin and caffeine. As with any concurrent use, professional consultation is the standard protocol for specific medication combinations.

Q: Is Fevrin addictive or habit-forming?

The active ingredient in Fevrin, Acetaminophen (Paracetamol), is not scheduled as a controlled substance under the Controlled Substances Act. This classification indicates that the medication is generally not considered addictive or habit-forming by regulatory bodies.

Q: Why does the package insert mention a need for regular testing?

Regulatory guidelines recommend clinical monitoring of liver function, typically by checking hepatic enzymes (liver enzymes). Regulatory guidelines specify that this monitoring is particularly important when the drug is used continuously or near the maximum daily dose.

Q: Does Fevrin affect blood pressure?

While not a common occurrence, the official safety labeling does list hypotension (low blood pressure) as a rare adverse effect. This effect is specifically noted in association with the intravenous form of the drug, which is administered in controlled clinical settings.

Q: Can I crush or split Fevrin tablets?

For the extended-release tablet forms of Fevrin, regulatory instructions prohibit cutting, crushing, or dissolving the medication. This is because altering the tablet can interfere with the way the drug is intended to be released into the body over time.

Q: What does the research say about Fevrin's effects on mental alertness?

While official labeling does not contain an explicit warning about mental impairment, common side effects such as dizziness and headache are listed. These effects have the potential to impact a patient's general alertness and focus.

Q: What should I do if I experience a mild, non-serious side effect?

Official guidance focuses on identifying signs of worsening health or serious reactions. Official guidance directs patients to contact their doctor if symptoms worsen, new or unexpected symptoms develop, or if pain or fever continues beyond the maximum time frame noted on the label.

Q: Is Fevrin a controlled substance?

Fevrin's active ingredient is Acetaminophen (Paracetamol), and on its own, it is not classified as a controlled substance under the Controlled Substances Act. This means it is not subject to the same strict prescribing and dispensing regulations as scheduled drugs.

Q: What type of specialist typically prescribes Fevrin?

Since Fevrin is widely available as an Over-the-Counter (OTC) product for treating common, short-term symptoms, a prescription is not always required. However, for chronic use, certain high-strength formulations, or intravenous administration, the drug is managed by licensed healthcare professionals.

Q: What are the signs of a serious allergic reaction to Fevrin?

Signs of a serious allergic reaction described in official safety documents include difficulty breathing or swallowing, swelling of the face, lips, tongue, or throat, or hives and itching. Severe skin reactions, such as blistering or peeling skin, are also noted as potential signs of a serious health concern.

Q: Do I need to change my diet while on Fevrin?

The official label provides a strong caution related to the chronic consumption of three or more alcoholic drinks per day due to the risk of liver damage. No other general mandatory dietary changes are specified in the regulatory product information.

Q: What is the difference between the strengths of Fevrin that are available?

The medication is manufactured in multiple strengths and physical forms, including oral solutions, suspensions, and tablets, such as the 325 mg and 500 mg doses. These different strengths are intended to align with the varying dosage requirements for specific age groups and patient weights.

Q: How long does Fevrin stay in the body after the last dose?

Pharmacokinetic studies indicate that the drug's elimination half-life—the time it takes for half the drug to be cleared—is typically between 1 to 3 hours. Regulatory information suggests that approximately 98% of a single dose of the medication is eliminated from the body within 24 hours.

Q: Is Fevrin effective for all stages of the condition it is approved to treat?

The research summaries indicate that most clinical findings are based on studies of patient cohorts experiencing fluctuating or episodic symptoms. The results are generally described as applying to the specific populations and limited time frames studied, rather than to all possible stages of the condition.

Q: Are there any ongoing or recently completed clinical trials for Fevrin?

Official research overviews state that investigations are ongoing regarding the drug's efficacy and safety. This includes studies focused on specific populations and comparative research examining the drug against newer or alternative treatment options.

Q: What is the definition of 'contraindication' as it relates to Fevrin?

A contraindication is a circumstance, such as a known allergy or severe liver impairment, in which regulatory bodies determine that the drug should not be administered because the risks outweigh the benefits. Key contraindications for Fevrin include known hypersensitivity (allergy) to the active ingredient and severe hepatic impairment (liver disease).

Q: What should be done if an overdose of Fevrin is suspected?

Official guidance mandates that if an overdose of Fevrin is suspected, immediate emergency medical attention is required, even if symptoms are not apparent. This is a critical instruction because the risk of delayed, severe liver damage exists.

Q: Does Fevrin interact with birth control pills?

Some regulatory-related summaries note a potential for the active ingredient to alter the plasma concentration of components in certain oral contraceptives. However, the clinical significance of this interaction for most users is often considered minor or undetermined.

Q: Does Fevrin have warnings about driving or operating machinery?

Official regulatory labeling does not contain a blanket warning explicitly prohibiting driving or operating machinery for all users. However, because reported common side effects include dizziness and headache, patients are generally advised to monitor their individual response to the medication.

Q: Are there different brand names for the same active ingredient as Fevrin?

Yes, the active ingredient in Fevrin, Acetaminophen (Paracetamol), is an established and widely recognized compound. Consequently, it is sold under multiple different brand names around the world in addition to being available generically.

Q: What is the primary way Fevrin is eliminated from the body?

The body processes Fevrin through a process called metabolism which primarily occurs in the liver using specific chemical pathways. After this breakdown, the resulting metabolites are then largely eliminated from the body via excretion through the kidneys in the urine.

How should Fevrin be stored and disposed of?

How to Store and Dispose of Fevrin (Acetaminophen/Paracetamol)

Fevrin must be stored according to official regulatory labeling to ensure product integrity.

Official Storage Conditions

The medication must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The product must be protected from excessive heat and moisture and stored away from direct light. It is mandatory to keep the product in its original container with the cap tightly closed. Liquid forms should not be frozen. As a strict safety mandate, Fevrin must always be kept out of the sight and reach of children.

Official Disposal Instructions

Unused or expired Fevrin should be disposed of through an official drug take-back program. If a take-back option is unavailable, the product may be mixed with an undesirable substance (e.g., cat litter) and sealed in a container before disposal in the household trash. The product must not be flushed down the toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fevrin found in:

A-Z Index: